Department of Pathology, University of Wisconsin, Madison, WI, United States.
Department of Pharmacology, Toxicology, and Therapeutics and the Kansas Intellectual and Developmental Disabilities Research Center, University of Kansas Medical Center, Kansas City, KS, United States.
CNS Neurol Disord Drug Targets. 2018;17(3):216-232. doi: 10.2174/1871527317666180412153612.
BACKGROUND & OBJECTIVE: A number of neuropsychiatric disorders, including Parkinson's disease, schizophrenia, attention deficit hyperactivity disorder, and, to some extent, depression, involve dysregulation of the brain dopamine systems. The etiology of these diseases is multifactorial, involving genetic and environmental factors. Evidence suggests that inadequate levels of n-3 (omega- 3) polyunsaturated fatty acids (PUFA) in the brain may represent a risk factor for these disorders. These fatty acids, which are derived from the diet, are a major component of neuronal membranes and are of particular importance in brain development and function. Low levels of n-3 PUFAs in the brain affect the brain dopamine systems and, when combined with appropriate genetic and other factors, increase the risk of developing these disorders and/or the severity of the disease. This article reviews the neurobiology of n-3 PUFAs and their effects on dopaminergic function.
Clinical studies supporting their role in the etiologies of diseases involving the brain dopamine systems and the potential of n-3 PUFAs in the treatment of these disorders are discussed.
包括帕金森病、精神分裂症、注意力缺陷多动障碍在内的多种神经精神疾病,以及在某种程度上的抑郁症,均涉及大脑多巴胺系统的失调。这些疾病的病因是多因素的,涉及遗传和环境因素。有证据表明,大脑中 n-3(ω-3)多不饱和脂肪酸(PUFA)水平不足可能是这些疾病的一个风险因素。这些脂肪酸来源于饮食,是神经元膜的主要成分,对大脑发育和功能尤为重要。大脑中 n-3 PUFAs 水平低会影响大脑多巴胺系统,并且与适当的遗传和其他因素结合,会增加患上这些疾病的风险和/或疾病的严重程度。本文综述了 n-3 PUFAs 的神经生物学及其对多巴胺能功能的影响。
讨论了支持 n-3 PUFAs 在涉及大脑多巴胺系统的疾病的发病机制中的作用的临床研究,以及 n-3 PUFAs 治疗这些疾病的潜力。